Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Grossman

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
Journal of Neuro-Oncology|March 26, 2013
'Elderly' patients with newly diagnosed glioblastoma deserve optimal careMatthias Holdhoff, Gary L Rosner, Sara Alcorn, et al.
Cancer Investigation|February 26, 2013
Treatment-related lymphopenia in patients with stage III non-small-cell lung cancerJian L Campian, Xiaobu Ye, Malcolm Brock, et al.
Journal of Neuro-Oncology|May 15, 2013
Blood-based biomarkers for malignant gliomasMatthias Holdhoff, Susannah G Yovino, Osei Boadu, et al.
Current Neuropharmacology|February 1, 2022
Transient Opening of the Blood-Brain Barrier by Vasoactive Peptides to Increase CNS Drug Delivery: Reality Versus Wishful Thinking?Matthew A Smith-Cohn, Nicholas B Burley, Stuart A Grossman
Oncotarget|January 27, 2018
Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitorsAdam Diehl, Mark Yarchoan, Alex Hopkins, et al.
Neuro-Oncology|January 5, 2002
A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomasJana Portnow, Samia Suleman, Stuart A Grossman, et al.
Journal of Neuro-Oncology|March 15, 2011
Tissue concentration of systemically administered antineoplastic agents in human brain tumorsMarshall W Pitz, Arati Desai, Stuart A Grossman, et al.
CNS Oncology|July 19, 2017
Late post-treatment radiographic changes 3 years following chemoradiation for glioma: the importance of histopathologyJoao R Galante, Fausto Rodriguez, Stuart A Grossman, et al.
Cancer Investigation|July 21, 2012
The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreasAni Balmanoukian, Xiaobu Ye, Joseph Herman, et al.
CNS Oncology|October 29, 2015
Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapyPrakash Ambady, Matthias Holdhoff, David Bonekamp, et al.
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Journal of Neuro-Oncology|March 26, 2013
'Elderly' patients with newly diagnosed glioblastoma deserve optimal careMatthias Holdhoff, Gary L Rosner, Sara Alcorn, et al.
Cancer Investigation|February 26, 2013
Treatment-related lymphopenia in patients with stage III non-small-cell lung cancerJian L Campian, Xiaobu Ye, Malcolm Brock, et al.
Journal of Neuro-Oncology|May 15, 2013
Blood-based biomarkers for malignant gliomasMatthias Holdhoff, Susannah G Yovino, Osei Boadu, et al.
Current Neuropharmacology|February 1, 2022
Transient Opening of the Blood-Brain Barrier by Vasoactive Peptides to Increase CNS Drug Delivery: Reality Versus Wishful Thinking?Matthew A Smith-Cohn, Nicholas B Burley, Stuart A Grossman
Oncotarget|January 27, 2018
Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitorsAdam Diehl, Mark Yarchoan, Alex Hopkins, et al.
Neuro-Oncology|January 5, 2002
A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomasJana Portnow, Samia Suleman, Stuart A Grossman, et al.
Journal of Neuro-Oncology|March 15, 2011
Tissue concentration of systemically administered antineoplastic agents in human brain tumorsMarshall W Pitz, Arati Desai, Stuart A Grossman, et al.
CNS Oncology|July 19, 2017
Late post-treatment radiographic changes 3 years following chemoradiation for glioma: the importance of histopathologyJoao R Galante, Fausto Rodriguez, Stuart A Grossman, et al.
Cancer Investigation|July 21, 2012
The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreasAni Balmanoukian, Xiaobu Ye, Joseph Herman, et al.
CNS Oncology|October 29, 2015
Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapyPrakash Ambady, Matthias Holdhoff, David Bonekamp, et al.
Pageof 18